In Hwan Lim

Title: In Hwan Lim: Innovator in Protein Production

Introduction

In Hwan Lim is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the production of dual function proteins. With a total of 3 patents to his name, Lim's work has the potential to impact various therapeutic applications.

Latest Patents

One of his latest patents is titled "Method for producing dual function proteins and its derivatives." This innovative method involves the production of a biologically active protein alongside an FGF21 mutant protein. The technique allows for the stable production of the target protein by effectively preventing its decomposition, showcasing high commercial potential. Another significant patent is the "Fusion protein comprising thyrotropin receptor variants and use thereof." This patent discloses a fusion protein that includes a thyrotropin receptor fragment and highlights its improved pharmaceutical efficacy, in-vivo persistence, and protein stability. The fusion protein is particularly useful as a therapeutic agent or diagnostic reagent for conditions such as Graves' disease and Graves' ophthalmopathy.

Career Highlights

Throughout his career, In Hwan Lim has worked with prominent organizations, including Yuhan Corporation and Yonsei University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Lim has collaborated with notable colleagues such as Byung Hyun Choi and Moo Young Song. Their joint efforts have further advanced the research and development of innovative protein production methods.

Conclusion

In Hwan Lim's contributions to biotechnology, particularly in protein production, demonstrate his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing solutions that have the potential to improve therapeutic outcomes.